Inclusivity

Diversity
#Clinical trials #Diversity #Drug development #Drug discovery #FDA #Inclusivity

Opinion: Are FDA plans enough to boost inclusivity within clinical trials?

DDW Editor Reece Armstrong examines whether recent FDA plans to boost diversity within clinical trials are enough to tackle the scale of the problem. In June this year, the US Food and Drug Administration (FDA) issued draft guidance designed to help boost the engagement of underrepresented communities within clinical… Read More

#Exclusive Content

Diversity
#Clinical trial design #Clinical trials #Diversity #Inato #Inclusivity #Investment #Oncology

$20 million in new funding to make clinical trials more inclusive

Clinical trial technology platform Inato, based in Paris, France, has closed a $20 million Series A funding from investors including Cathay Innovation, Obvious Ventures, La Maison and Top Harvest Capital. With the new funding, Inato will advance its diversity product offering to meet the new FDA… Read More

#Business & Investment #News #Start-up Zone

Diversity
#Clinical research #Clinical trials #Diversity #Ethnic populations #Inclusivity

New technology aims to improve diversity in clinical trials

Medidata has launched the Intelligent Trials Diversity Module to help improve the equity of clinical trials. The module will provide site-level participant demographic data including race, sex, age, and ethnicity.  The new Intelligent Trials Diversity Module will help sponsors identify sites that are more successful at enrolling diverse patients. Read More

#News